Three-D Receptor Structures 'Will Aid Drug Development'
By Sharon Kingman
Monday, July 29, 2013
LONDON New oral drugs for diverse conditions such as diabetes, osteoporosis, depression and anxiety have edged closer to development as a result of new information about the structure of an important class of hormone receptor. Scientists have worked out the three-dimensional structure of two of the Class B family of G protein-coupled receptors (GPCRs). Those receptors interact with a range of hormones and represent drug targets for many different diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.